lenalidomide krka d.d. novo mesto (previously lenalidomide krka)
krka, d.d., novo mesto - lenalidomide hydrochloride monohydrate - multiple myeloma; lymphoma, follicular - immunosuppressiva - multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) er indiceret til behandling af voksne patienter med tidligere ubehandlet myelomatose, der ikke er berettiget til transplantation. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) er indiceret til behandling af voksne patienter med tidligere ubehandlet myelomatose, der ikke er berettiget til transplantation. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).
levosert one 20 mikrogram/24 timer intrauterint indlæg
gedeon richter plc. - levonorgestrel - intrauterint indlæg - 20 mikrogram/24 timer
levosert two 20 mikrog/24 timer intrauterint indlæg
gedeon richter plc. - levonorgestrel - intrauterint indlæg - 20 mikrog/24 timer
jaydess 13,5 mg intrauterint indlæg
bayer ab - levonorgestrel - intrauterint indlæg - 13,5 mg
jaydess 13,5 mg intrauterint indlæg
paranova danmark a/s - levonorgestrel - intrauterint indlæg - 13,5 mg
jaydess 13,5 mg intrauterint indlæg
2care4 aps - levonorgestrel - intrauterint indlæg - 13,5 mg
jaydess 13,5 mg intrauterint indlæg
abacus medicine a/s - levonorgestrel - intrauterint indlæg - 13,5 mg
jaydess 13,5 mg intrauterint indlæg
orifarm a/s - levonorgestrel - intrauterint indlæg - 13,5 mg
kyleena 19,5 mg intrauterint indlæg
bayer ab - levonorgestrel - intrauterint indlæg - 19,5 mg
kyleena 19,5 mg intrauterint indlæg
orifarm a/s - levonorgestrel - intrauterint indlæg - 19,5 mg